NCT06241053

Brief Summary

This study aims to determine the effect Multimodal physical therapy with and without McConnell taping on pain, functional limitation and severity of symptoms in patients with anterior knee pain.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 5, 2023

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

January 28, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 5, 2024

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 5, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 5, 2024

Completed
Last Updated

February 5, 2024

Status Verified

January 1, 2024

Enrollment Period

3 months

First QC Date

January 28, 2024

Last Update Submit

February 2, 2024

Conditions

Keywords

Anterior Knee PainMcConnell tapingPatellofemoral Pain Syndrome.

Outcome Measures

Primary Outcomes (3)

  • Visual Analog Scale

    Visual analog scale is a self-assessing questionnaire comprising 10cm line with 0 representing no pain and 10 is worst pain. Reliability of VAS in patients with anterior knee pain is .60 to .79 for usual pain and .88 for worst pain.

    4rth week

  • Lower Extremity Functional Scale

    The Lower Extremity Functional Scale is a questionnaire containing 20 questions about a person's ability to perform everyday tasks. The score for each task is separated in 5 categories "0" (extreme difficulty or unable to perform activity), "1" (quite a bit of difficulty), "2" (moderate difficulty), "3" (a little bit of difficulty) and "4" (no difficulty). The maximal function is 80 points.

    4rth week

  • Anterior Knee Pain Scale

    The Anterior Knee pain Scale questionnaire consist of 13 items assessing subjective symptoms and functional limitation of the patients with anterior knee pain. The score ranges from 0 (worst condition) to 100 (normal knee condition, no symptoms and no daily functional restrictions).

    4rth week

Study Arms (2)

Multimodal therapy with McConnell taping

EXPERIMENTAL

Multimodal therapy includes core exercises, hip exercises and vastus medialis training. MacConnell taping will be applied during exercise and then nearly for 18 hours according to patient's comfort.

Other: Multimodal therapy with McConnell taping

Multimodal therapy without McConnell taping

EXPERIMENTAL

Multimodal therapy includes core exercises, hip exercises and vastus medialis training.

Other: Multimodal therapy without McConnell taping

Interventions

Multimodal therapy includes core exercises, hip exercises and vastus medialis training. Core exercises include curls ups, toa taps, side planks, supine straight leg raising, side lying straight leg raising, prone knee flexion, draw foot circles in supine and side lying, prone cobra, hip and knee extension, weight bearing, hip flexion sitting on ball, wight bearing forward and backward on the ball, stairs up on Swiss ball. Hip training includes Hip abduction, Hip external rotation in standing and sitting. VMO muscle strengthening will includes squats with a ball.

Multimodal therapy with McConnell taping

Multimodal therapy without McConnell taping

Multimodal therapy without McConnell taping

Eligibility Criteria

Age17 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Age 17-35 years, both male and female.
  • Unilateral or bilateral pain lasting for more than 2-3 months.
  • Diagnosed with patellofemoral pain by orthopedic surgeon through clinical and radiological findings.
  • Positive patellofemoral grinding test, negative McCurry test and full knee range of motion.
  • Pain grade 3-6 by Visual Analogue Scale (VAS).
  • Pain at least in two of these positions: sitting for long time with knee bends, going up and down the stairs, squatting and running, kneeling.

You may not qualify if:

  • History of ligament sprain, meniscal injury, knee fracture, patellar dislocation and knee osteoarthritis.
  • True knee joint locking or giving away and tibial or iliotibial track tendinopathy.
  • Pregnancy.
  • Developmental dysplasia of hip and undergoing any medical treatment.
  • Spinal surgery and neurological disorders.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Usman Srawr

Lahore, Punjab Province, 54600, Pakistan

RECRUITING

Related Publications (2)

  • Foroughi F, Sobhani S, Yoosefinejad AK, Motealleh A. Added Value of Isolated Core Postural Control Training on Knee Pain and Function in Women With Patellofemoral Pain Syndrome: A Randomized Controlled Trial. Arch Phys Med Rehabil. 2019 Feb;100(2):220-229. doi: 10.1016/j.apmr.2018.08.180. Epub 2018 Sep 26.

    PMID: 30267667BACKGROUND
  • Motealleh A, Kordi Yoosefinejad A, Ghoddosi M, Azhdari N, Pirouzi S. Trunk postural control during unstable sitting differs between patients with patellofemoral pain syndrome and healthy people: A cross-sectional study. Knee. 2019 Jan;26(1):26-32. doi: 10.1016/j.knee.2018.10.002. Epub 2018 Nov 22.

    PMID: 30472048BACKGROUND

MeSH Terms

Conditions

Patellofemoral Pain Syndrome

Interventions

Combined Modality Therapy

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal Diseases

Intervention Hierarchy (Ancestors)

Therapeutics

Study Officials

  • Ahtsam Liaqat

    Riphah International University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participants of both groups will be informed about the possible risks and potential. benefits but they won't know which group they are placed in. The participants must sign consent forms agreeing to the experiment.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 28, 2024

First Posted

February 5, 2024

Study Start

November 5, 2023

Primary Completion

February 5, 2024

Study Completion

February 5, 2024

Last Updated

February 5, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Locations